Ofatumumab | Marketing Authorisations | MA | Europe | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
CDMO Prospector
- Demo Dashboard
Drugs in Dev.
News
Blog
Market Place
Login

Ofatumumab
Europe

LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

Contact Supplier

Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

Contact Supplier

pharmacompass-1-m-2025-11-03

Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

Contact Supplier

Jai Radhe Sales is your partner for all your sourcing needs.

Contact Supplier

pharmacompass-2-m-2025-11-03

Ofatumumab

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

1 API Suppliers, 1 JDMF

1 API Suppliers
1 JDMF

DEVELOPMENTS

26 Drugs in Development

26 Drugs in Development

FINISHED DOSAGE FORMULATIONS

13 FDF Dossiers, 2 FDA Orange Book, 7 Europe, 1 Canada, 2 Australia, 1 South Africa

13 FDF Dossiers
2 FDA Orange Book
7 Europe
1 Canada
2 Australia
1 South Africa

RELATED EXCIPIENT COMPANIES

1 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 5 Kirsch Pharma, 5 Actylis, 1 BASF, 3 Gangwal Chemicals, 1 Nanjing Bold Chemical, 1 Pluviaendo, 6 Seppic

1 Nanjing Well Pharmaceutical
1 Pfanstiehl
5 Kirsch Pharma
5 Actylis
1 BASF
3 Gangwal Chemicals
1 Nanjing Bold Chemical
1 Pluviaendo
6 Seppic

EXCIPIENTS BY APPLICATIONS

13 Parenteral, 10 Solubilizers, 4 Thickeners and Stabilizers, 3 Surfactant & Foaming Agents, 3 Emulsifying Agents, 3 Topical, 2 Film Formers & Plasticizers, 2 API Stability Enhancers, 1 Direct Compression, 1 Rheology Modifiers, 1 Co-Processed Excipients

13 Parenteral
10 Solubilizers
4 Thickeners and Stabilizers
3 Surfactant & Foaming Agents
3 Emulsifying Agents
3 Topical
2 Film Formers & Plasticizers
2 API Stability Enhancers
1 Direct Compression
1 Rheology Modifiers
1 Co-Processed Excipients

DIGITAL CONTENT

58 News #PharmaBuzz

58 News #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 6 Annual Reports

1 US Medicaid Prescriptions
6 Annual Reports

PATENTS & EXCLUSIVITIES

6 Health Canada Patents

6 Health Canada Patents

Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

7 All

01 3Novartis Europharm Limited

02 2Novartis Ireland Limited

03 2Novartis Pharma Schweiz Ag

filter Active Ingredients Reset all filters

7 All

01 5Ofatumumab

02 2Ofatumumabum

filter Dosage Form Reset all filters

7 All

01 2Concentrate For Solution For Infusion

02 1Injectable Solution In Pre-Filled Pen

03 4Solution For Injection

filter Country Reset all filters

7 All

01 1Spain

02 4Sweden

03 2Switzerland

filter Brand Name Reset all filters

7 All

01 2Arzerra

02 5Kesimpta

List of Suppliers

Product Main Page

01

Novartis Ireland Limited

Florida Innovation

Not Confirmed

Novartis Ireland Limited

Florida Innovation

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Approved

Registration Country : Sweden

Brand Name : Kesimpta

Dosage Form : Solution For Injection

Dosage Strength : 20mg

Packaging :

Approval Date : 26/03/2021

Application Number : 20200110000103

Regulatory Info : Approved

Registration Country : Sweden

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

Novartis Ireland Limited

Florida Innovation

Not Confirmed

Novartis Ireland Limited

Florida Innovation

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Approved

Registration Country : Sweden

Brand Name : Kesimpta

Dosage Form : Solution For Injection

Dosage Strength : 20mg

Packaging :

Approval Date : 26/03/2021

Application Number : 20200110000097

Regulatory Info : Approved

Registration Country : Sweden

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

Novartis Europharm Limited

Florida Innovation

Not Confirmed

Novartis Europharm Limited

Florida Innovation

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Deregistered

Registration Country : Sweden

Brand Name : Arzerra

Dosage Form : Concentrate For Solution For Infusion

Dosage Strength : 100mg

Packaging :

Approval Date : 19/04/2010

Application Number : 20090310000023

Regulatory Info : Deregistered

Registration Country : Sweden

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

Novartis Europharm Limited

Florida Innovation

Not Confirmed

Novartis Europharm Limited

Florida Innovation

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Deregistered

Registration Country : Sweden

Brand Name : Arzerra

Dosage Form : Concentrate For Solution For Infusion

Dosage Strength : 1000mg

Packaging :

Approval Date : 21/02/2011

Application Number : 20110319000036

Regulatory Info : Deregistered

Registration Country : Sweden

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

05

Novartis Pharma Schweiz Ag

Florida Innovation

Not Confirmed

Novartis Pharma Schweiz Ag

Florida Innovation

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Allowed

Registration Country : Switzerland

Ofatumumabum

Brand Name : Kesimpta

Dosage Form : Solution For Injection

Dosage Strength : 20mg/0.4ml

Packaging :

Approval Date : 01/02/2021

Application Number : 67757

Regulatory Info : Allowed

Registration Country : Switzerland

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

06

Novartis Pharma Schweiz Ag

Florida Innovation

Not Confirmed

Novartis Pharma Schweiz Ag

Florida Innovation

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Allowed

Registration Country : Switzerland

Ofatumumabum

Brand Name : Kesimpta

Dosage Form : Solution For Injection

Dosage Strength : 20mg/0.4ml

Packaging :

Approval Date : 01/02/2021

Application Number : 67758

Regulatory Info : Allowed

Registration Country : Switzerland

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

07

Novartis Europharm Limited

Florida Innovation

Not Confirmed

Novartis Europharm Limited

Florida Innovation

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Authorized

Registration Country : Spain

Brand Name : Kesimpta

Dosage Form : Injectable Solution In Pre-Filled Pen

Dosage Strength : 20MG

Packaging :

Approval Date : 2021-05-10

Application Number : 121532003

Regulatory Info : Authorized

Registration Country : Spain

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!